Skip to main content
. 2023 Aug 23;3(8):1628–1637. doi: 10.1158/2767-9764.CRC-23-0145

TABLE 1.

Baseline characteristics

Characteristic All patients (n = 6)
Median age, years (range) 55 (40–72)
Hormone receptor positive, n (%) 2 (33%)
Triple negative, n (%) 4 (67%)
Median initial tumor size in largest dimension, cm (range) 3.35 (1.5–6.5)
Prior chemotherapy, n (%) 4 (67%)
Recurrence, n (%) 3 (50%)
Positive nodes, n (%) 4 (67%)
Stage I, n (%) 1 (16%)
Stage II, n (%) 2 (33%)
Stage III, n (%) 3 (50%)